Marksans Pharma Limited Share Price and Company Fundamentals



Price
₹47.95
Change
-1.400 (-2.837%)
52 week
38.6 - 91.3

Last traded: Yesterday at 9:59 AM

Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, distribution, and sale of generic pharmaceutical formulations in North America, Europe, the United Kingdom, Australia, New Zealand, and internationally. The company offers products in the analgesic, anti-inflammatory, benign prostatic hyperplasia, epilepsy, hyperparathyroidism, diabetic and antidiabetic, pain management, neurology, hormonal, antifungal, antiulcerative, cardiovascular and central nervous system, vitamin, cough and cold, dermatology, gastrointestinal, cephalosporin, injectable, antibacterial, hypertension, oncology, and antibiotics and anti-allergic therapeutic areas. It also provides contract research and manufacturing services, as well as distributes generic pharma products. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.

Key Metrics

PE ratio

9.60

PB ratio

1.47

Dividend yield

0.51%

Beta

1.28

Market cap

-

Enterprise value

-

Company profile

Industry / SectorDrug Manufacturers—General / Healthcare
Websitehttps://www.marksanspharma.com
Mailing addressGrandeur 11th Floor, Opp. Gundecha Symphony Veera Desai Ext Rd Oshiwara, Andheri (West) Mumbai 400053 India
Phone / Fax91 22 4001 2000 / 91 22 4001 2011

Dividends

Dividend yield

0.51%

Dividend amount

₹0.25

Payout ratio

5.54%

5Y Avg. yield

0.25%

Marksans Pharma Limited paid ₹0.25 dividend and the ex-dividend date was 15 Sept 2021.The dividend payout ratio is 5.54%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MARKSANS dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

MARKSANS's forward dividend amount is ₹0.25 and the forward dividend yield is 0.51%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Jul 2022, following are the company executives and directors listed on Marksans Pharma Limited.

NameTitleAgeTotal Pay
Mr. Mark B. SaldanhaNon-Independent Exec. Chairman, MD & CEO4910.43M
Mr. Jitendra M. SharmaChief Financial Officer52
Mr. Supratika TripathiDirector of Operations
Mr. Harshavardhan PanigrahiCompany Sec., Mang. of Legal & Compliance Officer
Ms. Sandra SaldanhaExec. Non-Independent Director507.03M
Mr. Varddhman Vikramaditya JainExec. & Non-Independent Director5114.68M
Mr. Sunil K. RaneSr. VP of QC52
Mr. Sopan PisalDirector of QA50
Mr. Sridhar NaiduGen. Mang. of HR & Admin42
Mr. Umesh RivankarHead of Domestic Marketing

Profitability and management effectiveness

Profit margin

12.19%

Operating margin

16.70%

Return on assets

11.15%

Return on equity

17.55%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Marksans Pharma Limited is and its enterprise value is .

The MARKSANS's stocks Beta value is 1.28 making it 28% more volatile compared to NSE market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Marksans Pharma Limited (NSE:MARKSANS) Frequently Asked Questions

1. What is Marksans Pharma Limited's Stock Symbol?

Marksans Pharma Limited trades on NSE under the ticker symbol "MARKSANS".

2. What is Marksans Pharma Limited's stock price today?

One share of MARKSANS stock can currently be purchased for approximately ₹47.95.

3. How can I contact Marksans Pharma Limited?

Marksans Pharma Limited's mailing address is Grandeur 11th Floor, Opp. Gundecha Symphony Veera Desai Ext Rd Oshiwara, Andheri (West) Mumbai 400053 India. The company can be reached via phone at 91 22 4001 2000.

4. What is Marksans Pharma Limited's official website?

The official website of Marksans Pharma Limited is https://www.marksanspharma.com.